Back to top
more

Evolent Health (EVH)

(Delayed Data from NYSE)

$24.57 USD

24.57
2,582,581

-0.20 (-0.81%)

Updated Nov 7, 2024 04:00 PM ET

Pre-Market: $15.95 -8.62 (-35.08%) 8:14 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (59 out of 251)

Industry: Internet - Software

Zacks News

Evolent Health (EVH) Reports Q2 Loss, Tops Revenue Estimates

Evolent Health (EVH) delivered earnings and revenue surprises of 66.67% and 2.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Evolent Health (EVH) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Evolent Health (EVH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are You Looking for a Top Momentum Pick? Why Evolent Health (EVH) is a Great Choice

Does Evolent Health (EVH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Evolent Health (EVH) Reports Q1 Loss, Tops Revenue Estimates

Evolent Health (EVH) delivered earnings and revenue surprises of 87.50% and 2.33%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Will Evolent Health (EVH) Report Negative Earnings Next Week? What You Should Know

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Phunware (PHUN) Surges: Stock Moves 9.9% Higher

Phunware (PHUN) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

Will Evolent Health (EVH) Report Negative Earnings Next Week? What You Should Know

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

eGain (EGAN) Hits 52-Week High, Can the Run Continue?

eGain (EGAN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Evolent Health (EVH) Reports Q2 Loss, Lags Revenue Estimates

Evolent Health (EVH) delivered earnings and revenue surprises of 70.00% and -1.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Chegg (CHGG) to Report Q2 Earnings: What's in the Offing?

Benefits from remote learning and rising subscribers are likely to get reflected in Chegg's (CHGG) Q2 performance.

Evolent Health (EVH) Expected to Beat Earnings Estimates: Should You Buy?

Evolent Health (EVH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are Options Traders Betting on a Big Move in Evolent Health (EVH) Stock?

Investors need to pay close attention to Evolent Health (EVH) stock based on the movements in the options market lately.

Will Evolent Health (EVH) Report Negative Earnings Next Week? What You Should Know

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolent Health (EVH) Reports Q4 Loss, Tops Revenue Estimates

Evolent Health (EVH) delivered earnings and revenue surprises of -75.00% and 1.47%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Company News for Nov 29, 2019

Companies In The News Are: CENT, BOX, DPLO, EVH

Options Traders Expect Huge Moves in Evolent Health (EVH) Stock

Investors need to pay close attention to Evolent Health (EVH) stock based on the movements in the options market lately.

Evolent Health (EVH) Reports Q3 Loss, Tops Revenue Estimates

Evolent Health (EVH) delivered earnings and revenue surprises of 40.00% and 1.31%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Evolent Health (EVH) to Report a Decline in Earnings: What to Look Out for

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Implied Volatility Surging for Evolent Health (EVH) Stock Options

Investors need to pay close attention to Evolent Health (EVH) stock based on the movements in the options market lately.

Evolent Health (EVH) Reports Q2 Loss, Lags Revenue Estimates

Evolent Health (EVH) delivered earnings and revenue surprises of -13.04% and -0.19%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolent Health (EVH) Reports Q1 Loss, Tops Revenue Estimates

Evolent Health (EVH) delivered earnings and revenue surprises of 8.82% and 2.91%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Evolent Health (EVH) to Report a Decline in Earnings: What to Look Out for

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolent Health (EVH) Reports Q4 Loss, Tops Revenue Estimates

Evolent Health (EVH) delivered earnings and revenue surprises of -75.00% and 2.36%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Evolent Health (EVH) Looks Good: Stock Adds 6.4% in Session

Evolent Health (EVH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.